Search results
Results from the WOW.Com Content Network
In August 2021, African Export-Import Bank awarded $400,000 grants to NIPRD to boost local production of active pharmaceutical ingredients. [6] In April 2022, the NIPRD signed a Memorandum of Understanding with the University of KwaZulu-Natal, South Africa, to improve the industry value chain for traditional medicine in Nigeria and Africa. [7]
Desirable policy strategies required for efficient conduct and performance of the industry include better government funding of research and development through the National Institute for Pharmaceutical Research and Development in collaboration with universities, support for the establishment of professional distribution network, completion of ...
The Raw Materials Research and Development Council (RMRDC) is a federal government of Nigeria agency for research institutions that is responsible for industrial raw materials growth, promotion and utilization supervised by Federal Ministry of Innovation, Science and Technology. [1] It has it head office at Maitama district Garki, Abuja. [2]
The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian federal agency under the Federal Ministry of Health that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, chemicals, and packaged water.
Ibrahim Hussaini Doko (24 September 1962) is a Nigerian academics, lecturer, administrator, and member of the Governing Board of the Raw Materials Research and Development Council, Nigeria. He is presently appointed as the director-general and chief executive officer of Raw Materials Research and Development Council , serving two terms from ...
The following is a list of countries by pharmaceutical exports.. Global sales from exported drugs and medicines by country total US$371.3 billion in 2018. Overall the value of drugs and medicine exports grew by an average 5.80% for all exporting countries since 2014 when drugs and medicines shipments were valued at $344.1 billion.
Several common factors can include: assurance of patient safety, assurance of the efficacy of the drug through the intended shelf life, [1] uniformity of the drug through different production lots, thorough documentation of all materials and processes, control of possible migration of packaging components into the drug, control of degradation ...
In the pharmaceutical industry, a wide range of excipients may be blended together with the active pharmaceutical ingredient to create the final blend used to manufacture the solid dosage form. The range of materials that may be blended (excipients, API), presents a number of variables which must be addressed to achieve target product quality ...